首页> 外文OA文献 >Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model

【2h】

Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model

机译：Anastrozole与富人在肿瘤内芳香酶异种移植模型的组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Luciana F. Macedo; Gauri J. Sabnis; Olga G. Goloubeva; Angela Brodie;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. FACT: An open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer [J] . BerghJ., J?nssonP.-E., LidbrinkE.K., Journal of Clinical Oncology . 2012,第16期

机译：事实：氟维司群与阿那曲唑联合单独使用阿那曲唑作为一线治疗的绝经后乳腺癌阳性患者的一线开放性随机III期研究
2. 18 Biological activity of a combination of fulvestrant 500 mg (F500) plus anastrozole versus F500 alone or anastrozole alone as neoadjuvant treatment for breast cancer [J] . J.F.R.Robertson, J.M.Dixon, D.M.Sibbering, European Journal of Cancer Supplements . 2010,第3期

机译：18氟维司群500 mg（F500）加阿那曲唑与单独F500或单独阿那曲唑组合作为乳腺癌新辅助治疗的生物学活性
3. ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole. [J] . Smollich M, Gotte M, Fischgrabe J, Breast cancer research and treatment. . 2010,第2期

机译：ETAR拮抗剂ZD4054在乳腺癌治疗中与芳香酶抑制剂和氟维司群具有叠加作用，并提高了阿那曲唑的体内疗效。
4. Combination of angiogenesis inhibitors increases the anti-tumor efficacy of photodynamic therapy in a human bladder tumor xenograft model [C] . Ramaswamy Bhuvaneswari, Yik Yuen Gan, Patricia SP Thong, World congress of the International Photodynamic Association . 2009

机译：血管生成抑制剂的组合增加了光动力疗法在人膀胱肿瘤异种移植模型中的抗肿瘤功效
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis [O] . Xing Huang 2019

机译：重新考虑氟维司群和阿那曲唑联合治疗转移性乳腺癌的方法：芳香化酶-雌激素受体轴的综合再分析
7. Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial [O] . Johnston Stephen RD, Kilburn Lucy S, Ellis Paul, 2013

机译：非激素芳香酶抑制剂在绝经后激素受体阳性的局部晚期或转移性乳腺癌（SoFEA）患者中非甾体芳香酶抑制剂治疗进展后，氟伐西坦加阿那曲唑或安慰剂与单独使用依西美坦相比：一项复合，多中心，3期随机试验

Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model

著录项

引文网络

相似文献

相关主题

期刊订阅